# Northeast Pharmaceutical

one of the world's three leading vitamin C suppliers, reported in March 2026 that its plants were running at full capacity, with vitamin C and piracetam output up nearly 15% year-on-year in the first two months of the year and core products passing multiple international customer audits.

Source: https://en.bioecon.ru/companies/northeast-pharmaceutical/
Updated: 2026-07-05

- Country: China
- Ticker: 000597.SZ

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | 2.006 billion yuan (Q1 2026) | https://disc.static.szse.cn/disc/disk03/finalpage/2026-04-28/aad71aba-91b7-4d10-a471-c80032a52c8a.PDF |
| Headcount | 5,727 (as of Dec 31, 2025) | https://stockanalysis.com/quote/she/000597/employees/ |
| Production site | two major production bases for active pharmaceutical ingredients and formulations (910,000 sqm and 180,000 sqm respectively) | http://www.nepharm.com/about/18.html |
| Capacity | plants running at full capacity (as of March 2026) | http://www.ln.xinhuanet.com/20260331/061b5d14f28640e5a8416967208f611a/c.html |
| Certification | EDQM, FDA, Japan MHLW, BRC, HALAL, KOSHER, ISO9001, FAMI-QS | http://www.nepharm.com/about/18.html |
| Regulatory approval | DCTY0801 injection clinical trial approval (2025); FDA orphan drug designation (2023) | http://static.cninfo.com.cn/finalpage/2026-04-03/1225077374.PDF, https://disc.static.szse.cn/disc/disk03/finalpage/2026-04-03/d1d4fbb6-1bee-4e21-98b3-351d94f3027f.PDF |

Independent sources: disc.static.szse.cn, ln.xinhuanet.com, nepharm.com, static.cninfo.com.cn, stockanalysis.com

## Technologies

- [Vitamins (D3, B-group, ascorbic acid)](https://en.bioecon.ru/technology/vitamins-d3-b-group-ascorbic-acid/)